ReviewRheumatology (Oxford, England)2019
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis.
Douglas J Veale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this paperpooled ittrialcites it